Testing the Adipose Expandability Hypothesis In Vivo During Overfeeding

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-42
SponsorPennington Biomedical Research Center

About this trial

Adipose, or fat, tissue is a plastic organ that retains the ability to expand and store excess calories during positive energy balance in humans. The capacity of subcutaneous (subQ) adipose tissue to expand and remodel is an important determinant of obesity-related health complications, and impaired expansion of subQ fat tissue is thought to contribute to the risk of diseases such as the Metabolic Syndrome (MetS) and type 2 diabetes mellitus (T2D). The objectives of the study are to evaluate the changes and mechanisms of (subQ) adipose tissue expandability that occur as a result of short-term weight gain and to investigate the effects on cardio-metabolic health outcomes. Findings from this study will provide new insight into the dynamics of adipose expansion and remodeling during changes in energy balance and how this may impact future fat tissue function and metabolic health.

Eligibility criteria

Qualifiers

Men and pre-menopausal women

18-42 years of age

BMI 23-35 kg/m2 (± 0.5 will be accepted)

Are willing to drink deuterium-labeled water (2H2O) for 8 weeks

Disqualifiers

Unstable weight in the last 3 months (± ~5% weight change)

Diagnosis of Type 1 or 2 diabetes or a fasting blood glucose > 110 mg/dL

Average screening blood pressure > 140/90 mmHg

Diagnosis of major organ disease (e.g. heart, kidney, lung, thyroid, liver disease) or abnormal liver enzymes that are, in the opinion of the MI, clinically significant and represent a problem for study inclusion.

Trial design

Treatments tested in this trial

  • Control
  • Overfeeding

Treatment groups

58 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Pennington Biomedical Research Center

Lead sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator